Karuna Therapeutics

About

Karuna Therapeutics is a Massachusetts-based developer of drugs for the treatment of schizophrenia.

Boston,Massachusetts,United States
101 - 250
https://karunatx.com

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $750M
Industries: Biotechnology,Health Care,Pharmaceutical
Founded date: Jan 1, 2009
Number Of Employee: 101 - 250
Operating Status: Active
Stock Symbol: nasdaq:KRTX
Legal Name: Karuna Therapeutics, Inc
Also Known As: Karuna Pharmaceuticals

Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

7

$1.20B

Karuna Therapeutics has raised a total of $1.20B in funding over 2 rounds. Their latest funding was raised on Aug 9, 2022 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 9, 2022	Post-IPO Equity	$750M	—	—	—	Detail
Mar 1, 2021	Post-IPO Equity	$250M	—	—	—	Detail
Jun 27, 2019	IPO	$89.24M	—	—	—	Detail
Mar 18, 2019	Series B	$68M	10	ARCH Venture Partners	—	Detail
Aug 2, 2018	Series A	$42M	4	ARCH Venture Partners	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

11

Karuna Therapeutics is funded by 11 investors. ARCH Venture Partners and Alexandria Venture Investments are the most recent investors.

Investor Name	Lead Investor	Funding Round
ARCH Venture Partners	Yes	Series B
Alexandria Venture Investments	—	Series B
Eventide	—	Series B
Fidelity Management and Research Company	—	Series B
Partner Fund Management	—	Series B
Pivotal bioVenture Partners	—	Series B
PureTech Health	—	Series B
Sands Capital Ventures	—	Series B
Sofinnova Investments	—	Series B
Wellcome Trust	—	Series B